Tenofovir Alafenamide for HBV Prophylaxis in HBV(-) Liver Transplant Recipients With HBcAb+ Donors
NCT04703465
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
HBV
Liver Transplant Disorder
Interventions
DRUG:
Tenofovir Alafenamide 25 MG
Sponsor
RenJi Hospital